Viewing Study NCT04428502


Ignite Creation Date: 2025-12-25 @ 3:56 AM
Ignite Modification Date: 2025-12-26 @ 2:47 AM
Study NCT ID: NCT04428502
Status: COMPLETED
Last Update Posted: 2021-09-14
First Post: 2020-06-10
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-07-05
Start Date Type: ACTUAL
Primary Completion Date: 2020-08-30
Primary Completion Date Type: ACTUAL
Completion Date: 2020-08-30
Completion Date Type: ACTUAL
First Submit Date: 2020-06-10
First Submit QC Date: None
Study First Post Date: 2020-06-11
Study First Post Date Type: ACTUAL
Results First Submit Date: 2021-08-17
Results First Submit QC Date: None
Results First Post Date: 2021-09-14
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-08-17
Last Update Post Date: 2021-09-14
Last Update Post Date Type: ACTUAL